Prenatal Testing
Maternal serum alpha-fetoprotein (MSAFP)-Plus, or triple screen is a blood test that a woman will have around 15-20 weeks of pregnancy it is essential in early diagnosis of trisomy 18. Other possible tests that can be performed are amniocentesis, and a level II ultrasound commonly known as a sonography. Chorionic villus sampling (CVS) or the removal of a small piece is removed from the side of the placenta. This is done anywhere from 10-12 weeks of pregnancy and can determine the severity of the condition because the placenta will have the same cellular genetic structure as the child. Lastly individuals can pay to speak to a genetic councilor to see the probability of having a child with this condition. As discussed two healthy parents can have a child with chromosomal disorder but by going to a genetic councilor the pair will be aware of any translocation of exchange of genetic material that may have occurred.
Diagnosis
Before a cure and treatment can be determined the severity of the symptoms must be observed, Every newborn is born with different combinations of abnormalities than can be difficult in finding a solution for the proper treatments. By following a check list as above and by examining each key piece of evidence a physician is able to determine if a child will have this condition. Regular check ups are scheduled each work to see if there is a worsening of symptoms. Several medications are given for the conditions such as heart abnormalities and respiratory problems. Some newborn children are also given oxygen or a feeding tube can be inserted in order to ensure their health.